-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, PmQKGAUiORnuG4okGE4Lu4TngU5Xmuc0HOVX256bGOz2tvcXD1pvUqFAd2bEx4hZ nNiD03xU/TwHOBsnDs2yEA== 0001193125-05-101141.txt : 20050510 0001193125-05-101141.hdr.sgml : 20050510 20050509175955 ACCESSION NUMBER: 0001193125-05-101141 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20050509 ITEM INFORMATION: Completion of Acquisition or Disposition of Assets ITEM INFORMATION: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20050510 DATE AS OF CHANGE: 20050509 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CENTENE CORP CENTRAL INDEX KEY: 0001071739 STANDARD INDUSTRIAL CLASSIFICATION: HOSPITAL & MEDICAL SERVICE PLANS [6324] IRS NUMBER: 041406317 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-31826 FILM NUMBER: 05813269 BUSINESS ADDRESS: STREET 1: 7711 CARONDELET AVE CITY: ST LOUIS STATE: MO ZIP: 63105 BUSINESS PHONE: 3147254477 MAIL ADDRESS: STREET 1: 7711 CARONDELET AVE STREET 2: SUITE 800 CITY: ST LOUIS STATE: MO ZIP: 63105 8-K 1 d8k.htm FORM 8-K Form 8-K

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington D.C., 20549

 

Form 8-K

 

Current Report

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date Of Report (Date Of Earliest Event Reported): 05/09/2005

 

Centene Corporation

(Exact Name of Registrant as Specified in its Charter)

 

Commission File Number: 000-33395

 

Delaware

  42-1406317

(State or Other Jurisdiction of

  (I.R.S. Employer

Incorporation or Organization)

  Identification No.)

 

7711 Carondelet Avenue, Suite 800, St. Louis, MO 63105

(Address of Principal Executive Offices, Including Zip Code)

 

314-725-4477

(Registrant’s Telephone Number, Including Area Code)

 

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

[    ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

[    ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17CFR240.14a-12)

 

[    ] Pre- commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17CFR240.14d-2(b))

 

[    ] Pre- commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17CFR240.13e-4(c))

 



Items to be Included in this Report

 

Item 2.01    Completion of Acquisition or Disposition of Assets

 

On January 10, 2005 we entered into a definitive agreement to acquire the Medicaid assets of SummaCare, Inc., a wholly owned subsidiary of Summa Health System. On May 9, 2005, effective May 1, 2005, we completed the acquisition of these assets.

 

We paid approximately $21 million in cash and issued 318,735 shares of common stock as consideration. The cash purchase price was funded through our unregulated cash and investments and $10 million borrowed under our revolving credit agreement with various financial institutions and LaSalle Bank National Association as administrative agent and arranger. Pursuant to a registration rights agreement, we will file with the SEC a registration statement on Form S-3 for the resale of all shares of common stock issued in the acquisition.

 

Item 2.03.    Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

 

On May 6, 2005, in connection with our acquisition of the Medicaid assets of SummaCare, Inc. discussed under Item 2.01, we borrowed $10 million from our $100 million revolving credit agreement with various financial institutions and LaSalle Bank National Association as administrative agent and arranger to fund a portion of the purchase price. The borrowed funds may be repaid at any time before the expiration date of the credit agreement, which is September 14, 2009. We currently have $40 million in outstanding borrowings under the agreement. For a description of the material terms of our revolving credit agreement see the Form 8-K filed with the Securities and Exchange Commission on September 16, 2004.

 

Item 9.01.    Financial Statements and Exhibits

 

  (c) Exhibits

 

  See Exhibit index attached hereto.

Signature(s)

 

Pursuant to the Requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the Undersigned hereunto duly authorized.

 

       

        Centene Corporation

    Date: May 09, 2005.   By:   /s/    Michael F. Neidorff        
           

Michael F. Neidorff

Chairman and CEO


Exhibit Index

 

Exhibit No.

  

Description                                                                                          


10.1 *    Asset Sale and Purchase Agreement, by and among Centene Corporation, Buckeye Community Health Plan, Inc., Summa Health System and SummaCare, Inc., dated January 10, 2005.

 

  * Incorporated by reference from the Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on April 25, 2005.
-----END PRIVACY-ENHANCED MESSAGE-----